Neos Therapeutics, Inc
NEOS
NEOS was delisted on the 19th of March, 2021.
49 hedge funds and large institutions have $65M invested in Neos Therapeutics, Inc in 2017 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 29 increasing their positions, 8 reducing their positions, and 5 closing their positions.
263% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 8
114% more capital invested
Capital invested by funds: $30.4M → $65M (+$34.6M)
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
6% less funds holding
Funds holding: 52 → 49 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$11.6M |
| 2 |
BlackRock
New York
|
+$5.57M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$5.34M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.49M |
| 5 |
DA
DSC Advisors
Chicago,
Illinois
|
+$2.17M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northern Trust
Chicago,
Illinois
|
-$1.95M |
| 2 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$679K |
| 3 |
BAMCO Inc
New York
|
-$412K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$145K |
| 5 |
Morgan Stanley
New York
|
-$102K |
NEOS Hedge Fund Activity: Q1 2017 in Review
49 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Neos Therapeutics, Inc (NEOS) for Q1 2017, worth a combined $65M — up 114% from $30.4M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new NEOS positions and 5 closed out — a net gain of 1 holder — while 29 added to existing stakes and 8 trimmed.
The largest buyer was Deerfield Management, adding an estimated $11.6M. The largest seller was Northern Trust, cutting an estimated $1.95M.
- 49 institutional investors held Neos Therapeutics, Inc (NEOS) as of Q1 2017, down from 52 in Q4 2016.
- Funds reported $65M of Neos Therapeutics, Inc stock for Q1 2017, up 114% quarter-over-quarter.
- 6 funds opened new Neos Therapeutics, Inc positions in Q1 2017 and 5 closed out, a net change of +1 holder.
- The largest Neos Therapeutics, Inc buyer in Q1 2017 was Deerfield Management, an estimated $11.6M added.
- The largest Neos Therapeutics, Inc seller in Q1 2017 was Northern Trust, an estimated $1.95M sold.
Based on aggregated 13F filings for Q1 2017.